The Institute


Director: GIANLUCA DE BELLISThe Institute

E-Mail:  direzione*

Address: Via Fratelli Cervi, 93 - 20090 Segrate (Milan)

Phone: (+39) 02 26422702 - 02 26422708
Fax: (+39) 02 26422770

Sections:  Pisa, Rome, Bari

Research area: Biomedicine

Research fields: Human Genome, Medical genomics, Degenerative diseases, Proteomics and nanotechnologies, molecular oncology, stem cell/cancer stem cell research, Biochemistry of metalloproteines, Bioinformatics and comparative genomics, Immunobiology and cellular differentiation, Epidemiology and medical informatics, Bioinformatics and System Biology for health.

The Mission


The National Research Council (CNR) is the primary government agency with the task to foster exceptional basic, biomedical and clinical research through its participating intramural and extramural programs. Within the CNR, the National Institute of Biomedical Technologies (ITB), a newly re-established institute in May 2002, derives from the merge of different institutes and units of the CNR, among which was the ITBA (Institute of Advanced Biomedical Technologies).

The main location of the ITB is in Segrate near Milan at the Advanced Technology Interdisciplinary Laboratory (LITA). This facility hosts various departments of the University of Milan that formally collaborate with the ITB Associated branch sections also include the Department of Bioinformatics and Comparative Genomics in Bari, the Department of Biochemistry of Metal-Proteins in Padova and the Immuno-Biology and Cell Differentiation Unit in Pisa.The ITB campus in Segrate (MI) has over 2500 square meters of laboratories and offices, more that 50 employees and at any one time more than 30 collaborating doctorates, fellowships and contractors from public and private organizations. A growing list of institutions around the world collaborate with the ITB in the fields of stem cell research, oncology, neurodegenerative disorders, immunodeficiency and bone related diseases, and developmental biology associated research.

Strong pre-doctoral and post-doctoral training programs are established at the ITB to create a lasting bridge between academia, medical research and industry with the aim to foster future advancement of new bio-medical technologies. In addition, the ITB encourages the start up of new small to medium sized firms (PMI) and promotes their access to European, National and regional financial opportunities. Examples of extramural collaborations with the ITB include education, training and research projects funded by the European Community, the Cariplo Foundation, the Telethon Committee, the Italy- USA Cancer Pharmacogenomics Initiative, the Italian Association for Cancer Research and the M.J. Fox Foundation for Parkinson Research.


The ITB is the largest institute of its kind in Italy and was established to pioneer new types of cross-disciplinary biomedical research by bringing biology, engineering, medicine, and basic sciences together. This is achieved by means of collaborations between industry and basic scientists and clinicians from a broad range of disciplines. One of the most important aims of its research mission is translating fundamental discoveries into new technologies. In 1986 Renato Dulbecco, proposed to the scientific community the sequencing of the human genome. This initiative later became known as the Human Genome Project (HGP), where a broad section of the Institute in collaboration with Renato Dulbecco worked on this project. Since 1986, from the HGP, tremendous technological advances have been made that have important implications in future discoveries in biological and clinical sciences.


For spamming reasons the @ symbol has been subsituted with *